Fractyl Health (GUTS) Assets Average (2024 - 2026)
Fractyl Health's (GUTS) quarterly Assets Average came in at $110.4 million in Q1 2026, up 15.52% YoY from $95.6 million in Q1 2025, and down 6.32% on a QoQ basis from $117.8 million in Q4 2025.
Fractyl Health (GUTS) Assets Average (2024 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 3 years of Assets Average data on file, last reported at $110.4 million in Q1 2026.
- Quarterly Assets Average rose 15.52% year-over-year to $110.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.4 million (up 15.52% YoY) and the FY2025 annual result came in at $114.7 million, up 24.52% from the prior year.
- Assets Average eased to $110.4 million in Q1 2026, from $117.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $155.0 million in Q2 2024 to a low of $72.5 million in Q2 2025.
- A 3-year average of $112.6 million and a median of $117.5 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2025 — Assets Average tumbled 53.2% — and 2026, when it advanced 15.52%.
- Tracing GUTS's Assets Average over 3 years: stood at $117.5 million in 2024, then advanced by 0.29% to $117.8 million in 2025, then dropped by 6.32% to $110.4 million in 2026.
- The last three Assets Average figures came in at $110.4 million (Q1 2026), $117.8 million (Q4 2025), and $88.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - | 90.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.68 Mn |
| Mar 31, 2026 | 110.39 Mn |
| Dec 31, 2025 | 117.84 Mn |
| Sep 30, 2025 | 88.14 Mn |
| Jun 30, 2025 | 72.52 Mn |
| Mar 31, 2025 | 95.56 Mn |
| Dec 31, 2024 | 117.50 Mn |
| Sep 30, 2024 | 136.68 Mn |
| Jun 30, 2024 | 154.98 Mn |
| Mar 31, 2024 | 119.87 Mn |